Apps

World Bank Mobilizes Record $112B Private Capital — 2dDeveloping economies face 1.2B young people reaching working age against ~420M projected jobs; World Bank says private capital hit a record $112B in FY26.

Maya Lindstrom Blending public guarantees with private funds is finally delivering real scale for developing economies.

Dr. David Crean Book Guides Biopharma Leaders on Commercialization — 1dA new book, Dual Fluency: Bridging Science, Capital, and Governance in Life Sciences by Dr. David H. Crean, offers a practical blueprint for biopharma to move from discovery to commercialization by focusing on three core translations—Data to Capital, Discovery to Deal, and Bench to Boardroom—along with Capital Stack Optimization. Aimed at scientist-founders, pre-commercial CEOs, BD executives, and investors, the work promises actionable risk-reduction insights and will be available on Amazon and major bookstores through Cardiff Advisory LLC.

Jared Kim This book seems helpful for scientist founders who struggle turning research into actual funding and governance plans.

Fed to Finalize Bank Stress-Test Reforms for Greater Transparency — 1dThe Fed plans to finalize two stress-test rules on model transparency and averaged buffers; Bowman expects capital buffer volatility to fall by half.

Chris Dalton Averaging the buffers should cut down on those big swings in required capital from year to year.

Host Digital Prices $17.5 Million Stock OfferingBusiness — 1dHost Digital Inc., formerly Healthy Choice Wellness Corp., announced a proposed underwritten public offering of Class A common stock priced at $8.00 per share for 2,187,500 shares (about $17.5 million gross) with a 30-day option for up to 328,125 additional shares, and the offering is expected to close around Sept. 21, 2026. Proceeds are earmarked for data center investments, general corporate purposes, capital expenditures and working capital, with Cantor Fitzgerald and partners serving as underwriters.

ByteDance Spins Out AI Drug Unit at $1.5B — 3dByteDance spun off its AI drug discovery unit, Anew Labs, into an independent company and just closed a $290 million first-round financing valuing it at about $1.5 billion, with ByteDance retaining a 56% controlling stake. The round, led by HSG, IDG Capital, Hillhouse, and 5Y Capital among others, bolsters Anew Labs’ global footprint and its pipeline and technology stack built around AI-driven drug discovery.

Class-Action Lawsuit Alleges AST SpaceMobile Misrepresented Capital Needs and Competition — 4dMultiple securities class actions have been filed against AST SpaceMobile alleging false and misleading statements about its capital needs, debt load, liquidity, and competitive position, including claims tied to the EchoStar transaction; investors who purchased ASTS securities during the specified period may pursue recovery, with lead-plaintiff deadlines and no out-of-pocket costs to participate. The actions are being led by Rosen Law Firm, Levi & Korsinsky, and Robbins Geller as they seek to represent shareholders affected by the alleged fraud between March 4, 2025 and July 15, 2026.

Enablence Closes C$25 Million Chip-Capacity Investment — 18hEnablence Technologies raised C$25 million in a private placement of 3,226,000 shares at C$7.75 to Collingwood Investments to fund expansion of capacity at its Silicon Valley and Vietnam fabrication sites and to bolster working capital amid growing datacom and AI demand, with investor rights and final TSX Venture Exchange approval being noted. The deal strengthens the company’s balance sheet and positions it to scale production, pending regulatory clearance.

Elena Vasquez This funding at 7.75 a share should let Enablence scale production fast enough to catch the AI orders.

Flights to and from Indonesia’s capital resume after volcanic eruption forced a 2-day closureWorld — Sep 8, 2026

Tailgate menus add grape-jelly meatballs and pumpkin cold brews — 2dA variety of tailgate-friendly bites—ranging from easy baked tacos and pizza-sliders to slow-cooker meatballs and Big Mac egg rolls—are highlighted as crowd-pleasing, shareable options for game-day spreads. The fall theme extends to beverages, with seasonal cocktails, customized coffee drinks, and low- and no-alcohol options being promoted across different venues to capitalize on autumn flavors like maple, cinnamon, apples, and pumpkin.

IAG Completes €500 Million Buyback ProgramFinance — Sep 11, 2026ICG Enterprise Trust repurchased 15,000 of its own shares at 1,431 pence and now holds 3,159,402 shares in treasury with 60,394,790 shares in issue (excluding treasury), under its long-term buyback authority. International Consolidated Airlines Group completed its second €500 million buyback, bringing total repurchases to €1 billion under a €1.5 billion capital-return plan, with 97,747,488 shares in treasury awaiting cancellation (about 2.12% of issued capital).

Electra Therapeutics Prices $350 Million Biotech IPO — 2dElectra Therapeutics priced an upsized $15-per-share IPO at roughly $350 million, selling 23,333,334 shares with a 30-day option for 3.5 million more and set to trade on Nasdaq as ETRA; proceeds will fund its ipsoprubart HLH program and other candidates as it scales its late-stage pipeline. The deal underscores strong investor demand for biotech IPOs in 2026, with Electra among multiple companies raising substantial capital for immune-mediated diseases and cancer programs.

Sam Okafor The proceeds should help push their late-stage candidates forward, though execution risk in biotech remains high.

Virbac Reports 7.4% H1 Growth, Confirms 2026 Guidance — 2dVirbac reported H1 2026 revenue of €768 million, up 7.4% organically with an 18.8% adjusted EBIT margin and €87.1 million net profit, while net debt rose to about €196 million due to seasonal working capital. Management reaffirmed 2026 targets at the upper end of a 5.5%–7.5% revenue-growth range and around 17% adjusted recurring operating margin, supported by the scaling of its Supercharge platforms and the Thyronorm integration across global markets as part of its 2030 strategy.

Derek Foss Reaffirming the upper end of 2026 guidance suggests the Thyronorm rollout and Supercharge platforms are on track.

Rapta Raises $8M to Expand AI Defense Manufacturing PlatformTech — 2dRapta raised $8 million to scale its AI-powered Manufacturing Intelligence Platform for defense, aerospace, and other precision manufacturing, unifying siloed production data with computer vision to deliver real-time work instructions and traceability across lines. The round, co-led by Voyager Capital and Access Venture Partners, adds new board members and positions Rapta to expand deployment among top defense primes, improving quality, documentation, and operational efficiency.

H.I.G. Capital taps former Blackstone executive to lead Asia expansion — Sep 1, 2026H.I.G. Capital has named Younghee Choi as Head of Asia in its Capital Formation Group, based in Hong Kong, to lead fundraising and investor relationships across the region and broaden its Asian limited partner base. A former Blackstone senior executive with 15+ years in capital formation, Choi will help connect Asian investors with H.I.G.’s private equity, credit and real assets platforms as the firm manages about $75 billion in capital and supports over 400 portfolio companies.

Derek Foss Curious how much of that $75B in AUM is actually deployed vs dry powder waiting for better entry points.

CVC Capital Partners to Name Sisitsky and Rutland Co-CEOs in 2028 — Sep 9, 2026CVC Capital Partners will appoint TPG's Todd Sisitsky as co-CEO alongside Peter Rutland, with the duo slated to take over from CEO Rob Lucas by Q1 2028 as the firm broadens beyond traditional private equity. Sisitsky will also chair the partner board, marking a notable external leadership change as CVC pursues a broader private-markets platform.

Brookfield Agrees to Acquire Reliance Worldwide for US$2.9 Billion — 3dBrookfield Capital Partners will acquire Reliance Worldwide Corporation (RWC) for US$3.38 per share, valuing the company at about US$2.9 billion, with a scheme of arrangement and a Go Shop period through 15 October 2026. The RWC board unanimously supports the deal, which offers USD or AUD payment options, carries premiums to recent trading levels, and is subject to shareholder, court, and regulatory approvals as well as an independent expert’s report.

Tom Gallagher Brookfield's offer at a premium looks decent for RWC shareholders but the long timeline to close could bring risks.

Positron AI Raises $875M at $5B Valuation — Sep 10, 2026Positron AI raised $875 million in a two‑tranche Series C that values the company at $5 billion and will fund the tapeout of its Asimov memory‑first chip and the production ramp of Titan, as well as expanding manufacturing for its Atlas system deployed at Oracle Cloud. The round, co-led by NEA, Atreides Management, Valor Equity Partners, Andra Capital, SemiAnalysis Capital, and Jim Clark, will also add new board members and accelerate LPDDR5X‑based memory bandwidth‑focused inference hardware designed for air‑ and liquid‑cooled data centers.

Maya Lindstrom Jim Clark backing the Atlas ramp at Oracle makes sense given his hardware history, though scaling Titan production will still face stiff competition.

Clearlake Completes Full Chelsea Takeover — 5dChelsea will move to full control by Clearlake Capital as Todd Boehly, Mark Walter and Hansjörg Wyss exit their stakes, with the club valued at about £5 billion including debt and Clearlake set to take complete ownership by year-end. Boehly will step down as chairman while Wyss remains a key stakeholder, and the transition could pave the way for stadium and training-ground upgrades.

DSS Halts Proposed Offering, Evaluates Capital Alternatives — Sep 4, 2026DSS, Inc. has been actively pursuing capital-raising via common stock offerings, with initial plans to sell shares to fund general corporate needs prompting a market reaction and concerns about dilution. Subsequently, the company indicated it would not proceed under its shelf registration due to capacity constraints, while another release announced a new public offering launch, underscoring ongoing efforts to access capital amid mixed signals to investors.

Nicole Hardy The back-and-forth on this offering is exactly why retail investors get whiplash. Pick a lane, DSS.

Syngenta Plans $5 Billion Hong Kong IPO — 4dSyngenta Group confidentially filed for a Hong Kong IPO, targeting about US$5 billion in proceeds and possibly up to US$10 billion, with a listing expected as early as next year depending on regulatory approvals and market conditions. The deal, potentially among Hong Kong’s largest in years, underscores Sinochem-owned Syngenta’s strategy to tap international capital for growth amid volatility in global crop markets.

Marcus Bell This Hong Kong listing could give Syngenta better access to Asian investors for expanding crop solutions.

AI Search Reshapes Local Business DiscoveryTech — 4dAI-driven local search is narrowing choices to a limited set of trusted sources, causing many brands to miss via AI recommendations even if they rank on Google, and elevating the need for distinct AI visibility strategies beyond traditional SEO. To capitalize on this shift, businesses should optimize for Answer Engine Optimization, maintain robust, well-structured data and reviews, and ensure clear, differentiating messaging across their profiles and content as AI increasingly informs local decision-making.

Ares, PSP Establish $2.4B U.S. Logistics JV — 2dAres Management and the Public Sector Pension Investment Board have launched a joint venture to invest up to $2.4 billion in U.S. logistics real estate, starting with a 5.2 million-square-foot seed portfolio of 14 properties in California, Texas, and New Jersey, with Marq Logistics leading sourcing and asset management. The venture combines Ares' real estate platform and PSP Investments' capital to target cash-flowing assets in high-growth markets amid growing demand from onshoring, digital infrastructure expansion, and e-commerce.

Tom Gallagher Starting with 5 million square feet already leased is a safer bet than chasing new builds in a crowded market.

BCB Bancorp prices $85.25M stock offering ahead of expected Q3 lossFinance — 2dBCB Bancorp launched an underwritten public offering of 11 million shares for about $85.25 million, with a 30-day option to sell additional shares, to bolster liquidity and capital while supporting the bank’s plan to dispose of identified problem loans; closing is expected around September 18, 2026. Simultaneously, the bank is marketing roughly $210 million of problem loans along with weaker CRE and cannabis-related loans for sale, with projected quarterly losses and tax-related valuation impacts as it works to restore balance sheet strength and profitability.

Nicole Hardy Raising capital ahead of the Q3 loss and tax hits looks like a proactive move to stabilize things and return to profitability.

Prosecutors Won’t Seek Death Penalty for Reiner — 4dNick Reiner, the son of Rob and Michele Reiner, is facing a multi-count murder indictment tied to the December Brentwood killings and is due in court for a pretrial hearing as prosecutors pursue charges that include murder with special circumstances such as lying in wait and the use of a knife. The district attorney has opted not to pursue the death penalty, influenced by the victims’ anti-execution views, a state moratorium on capital punishment, and family dynamics, while the defense seeks access to a $1.5 million trust fund to mount the defense as the case proceeds toward potential life-in-prison outcomes.

Marcus Bell Accessing that trust fund could let the defense actually prepare properly.

Discussions